Please use this identifier to cite or link to this item:
Title: MRI contrast enhancement of liver pre-neoplasia using iron-tannic nanoparticles
Authors: Thipjutha Phatruengdet
Jannarong Intakhad
Monreudee Tapunya
Arpamas Chariyakornkul
Chi Be Hlaing
Rawiwan Wongpoomchai
Chalermchai Pilapong
Keywords: Chemical Engineering
Issue Date: 24-Sep-2020
Abstract: © The Royal Society of Chemistry 2020. The most challenging part of liver cancer detection is finding it in the very early stages. It has been argued that liver preneoplasia is found at the very earliest stages of liver cancer. The presence of a lesion is closely related to the development of HCC. We report herein a new class of iron-based T1MRI contrast agents which are nanoparticles of iron-tannic complexes (so-called Fe-TA NPs) that can be used for detecting liver preneoplasia. Preliminary assessment of their toxicity in healthy rats provides suitable imaging dose ranges with acceptable toxicity. In diethylnitrosamine (DEN) induced rats, it is shown that Fe-TA NPs are capable of enhancing MRI signals in rat livers having pre-neoplastic lesions within 60 minutes post-injection. The enhancement efficacy is strongly dependent on the characteristics of pre-neoplastic foci (GST-P+ foci). The highest enhancement was in good correlation with the size of GST-P+ foci and amount of Fe-TA NPs accumulated in the liver, and might be caused by the dysfunction of liver sinusoids along with cellular uptake capability of pre-neoplastic hepatocytes. Our results show that Fe-TA NPs are of great interest to develop as an efficient MRI imaging agent for risk assessment of liver cancer.
ISSN: 20462069
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.